Table 1.
N | Sex | Age | Vaccine dose | Onset | Clinical features | Extracutaneous manifestations | Allergy‐related history |
---|---|---|---|---|---|---|---|
1 | F | 67 | 1° | 1 day | Itchy erythemato‐oedematous plaque at injection site | N | N |
2 | F | 61 | 2° | 2 days | Erythema & swelling of left foot dorsum | N | N |
3 | F | 55 | 1° | 8 days | Erythema and itch of face | Y | Y |
4 | F | 59 | 2° | 3 days | Diffuse erythematous rash | Y | Y |
5 | F | 62 | 1° | 1 h | Itchy erythemato‐oedematous plaque at injection site | Y | Y |
6 | F | 38 | 1° | 1 h | Erythema of both legs | Y | Y |
7 | M | 56 | 1° | 1 h | Urticaria at injection site | N | Y |
8 | F | 56 | 2° | 5 h | Diffuse erythematous rash of trunk | N | Y |
9 | M† | 29 | 1° | 7 days | Erythema and swelling of left chest | N | Y |
10 | M | 36 | 2° | 48 h | Diffuse erythematous rash of trunk | N | N |
11 | M | 32 | 1° | 2 days | Urticarial rash, flare‐up of atopic dermatitis | N | Y |
F, female; M, male; N, No; Y, yes.
Previous SARS‐CoV‐2 infection.